Organization
Breakthrough T1D
- Meetings this Parliament
- 63
- With MPs
- 36
- Since Nov 2021
- 93
- Active registrations
- 1
Most recent reported meeting: Jul 30, 2026.
Lobbying by Breakthrough T1D: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
In-house (organization) In effect since Jul 17, 2026
Filed by Jessica Diniz, President and Chief Executive Officer
Lobbyists
- Caroline Bouchard · National Director, Government Relations and Advocacy
- Dr. Sarah Linklater · Chief Science Officer
- Jessica Diniz · President & Chief Executive Officer
- Joey Wong · National GR and Advocacy Officer
- Kimberley Hanson · Chief External Relations Officer
Institutions they may lobby: Canada Revenue Agency (CRA), Canadian Institutes of Health Research (CIHR), Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC), Employment and Social Development Canada (ESDC), Finance Canada (FIN), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Senate of Canada, Treasury Board Of Canada Secretariat (TBS)
What they're lobbying on (9)Hide details
- Seek increased funding for type 1 diabetes research
- Discussions and information sharing on improving regulatory pathways for cell and gene therapy
- Discussions and information sharing around: Procurement and tariffs impact Insulin production Stock piles
- To seek funding to expand the foundation's educational program to raise awarenes of type 1 diabetes and diabetes management in Canada.
- Ensuring Bill C-64, the National Pharmacare Act, meets the needs of Canadians living with type 1 diabetes by having adequate insulin and diabetes devices coverage, while respecting patient choice.
- Seek an increase funding for the Canadian Clinical Trial Network to find a cure for Type 1 Diabetes (T1D).
- Ongoing conversation with Health Minister's Office regarding JDRF-CIHR Partnership to Defeat Diabetes renewal funding.
- Meeting with Juvenile Diabetes Caucus Co-Chairs to discuss strategies and tactics to move JDRF Canada Pre-Budget Submission priorities forward including additional funding for research towards a cure for type 1 diabetes
- Canadian Institutes of Health Research (CIHR) and the Strategy for Patient-Orientated Research (SPOR) Discussions with CIHR and SPOR Network about collaboration towards the creation of a type 1 diabètes registry
Registration 956508-243401-40. Look it up in the official Registry
Reported meetings
SpreadsheetFiled by Jessica Diniz (81), Dave Prowten (12).
-
Reported by Jessica Diniz · In-house (organization)
- Karen Sorensen · Senator, Senate of Canada
Seek increased funding for type 1 diabetes research
-
Reported by Jessica Diniz · In-house (organization)
- Sonia Sidhu · Member of Parliament
Seek increased funding for type 1 diabetes research
-
Reported by Jessica Diniz · In-house (organization)
- Anthony Lostracco · Manager, Health Canada (HC)
- Anthony Sabourin · Senior Corporate Regulatory Compliance & Enforcement Advisor, Health Canada (HC)
Discussions and information sharing around: Procurement and tariffs impact Insulin production Stock piles
-
Reported by Jessica Diniz · In-house (organization)
- Anthony Lostracco · Manager, Health Canada (HC)
Discussions and information sharing around: Procurement and tariffs impact Insulin production Stock piles
-
Reported by Jessica Diniz · In-house (organization)
- Sonia Sidhu · Member of Parliament
Seek increased funding for type 1 diabetes research
-
Reported by Jessica Diniz · In-house (organization)
- Anthony Lostracco · Manager, Health Canada (HC)
- Rodrigue Burnett · Senior Regulatory Affairs Officer, Health Canada (HC)
- Anthony Sabourin · Case Manager, Health Canada (HC)
Discussions and information sharing around: Procurement and tariffs impact Insulin production Stock piles
-
Reported by Jessica Diniz · In-house (organization)
- Mona Fortier · Member of Parliament
Seek increased funding for type 1 diabetes research
-
Reported by Jessica Diniz · In-house (organization)
- Maggie Chi · Parliamentary Secretary to the Minister of Health
Meeting with Juvenile Diabetes Caucus Co-Chairs to discuss strategies and tactics to move JDRF Canada Pre-Budget Submission priorities forward including additional funding for research towards a cure for type 1 diabetes Read more
-
Reported by Jessica Diniz · In-house (organization)
- Élisabeth Brière · Member of Parliament
- Chris d'Entremont · Member of Parliament
- Karen Sorensen · Senator, Senate of Canada
Meeting with Juvenile Diabetes Caucus Co-Chairs to discuss strategies and tactics to move JDRF Canada Pre-Budget Submission priorities forward including additional funding for research towards a cure for type 1 diabetes Read more
-
Reported by Jessica Diniz · In-house (organization)
- Karim Bardeesy · Parliamentary Secretary to the Minister of Industry, Innovation, Science and Economic Development Canada (ISED)
Seek increased funding for type 1 diabetes research
-
Reported by Jessica Diniz · In-house (organization)
- Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Seek increased funding for type 1 diabetes research
-
Reported by Jessica Diniz · In-house (organization)
- Maggie Chi · Parliamentary Secretary to the Minister of Health
Seek increased funding for type 1 diabetes research
-
Reported by Jessica Diniz · In-house (organization)
- Jade Mallette · Chief of Staff, Health Canada (HC)
- Shahad Khalladi · Senior Policy Advisor, Health Canada (HC)
Ensuring Bill C-64, the National Pharmacare Act, meets the needs of Canadians living with type 1 diabetes by having adequate insulin and diabetes devices coverage, while respecting patient choice. Read more
Seek increased funding for type 1 diabetes research
-
Reported by Jessica Diniz · In-house (organization)
- Richard Bragdon · Member of Parliament
- Kelly McCauley · Member of Parliament
- Branden Leslie · Member of Parliament
- Chris d'Entremont · Member of Parliament
and 19 moreShow fewer
- Tony Baldinelli · Member of Parliament
- Peter Schiefke · Member of Parliament
- Scott Reid · Member of Parliament
- John Brassard · Member of Parliament
- Marie-France Lalonde · Member of Parliament
- Salma Zahid · Member of Parliament
- Joël Godin · Member of Parliament
- Pat Kelly · Member of Parliament
- Percy Downe · Senator, Senate of Canada
- Patti LaBoucane-Benson · Senator, Senate of Canada
- Ken Hardie · Member of Parliament, House of Commons
- Mohamed-Iqbal Ravalia · Senator, Senate of Canada
- Abigail Aquino-Annobil · Assistant, House of Commons
- Jim Quinn · Senator, Senate of Canada
- Jenica Atwin · Member of Parliament, House of Commons
- Joyce Murray · Member of Parliament, House of Commons
- Michelle Ferreri · Member of Parliament, House of Commons
- Robert Kitchen · Member of Parlilament, House of Commons
- Karen Sorensen · Senator, Senate of Canada
Seek increased funding for type 1 diabetes research
-
Reported by Jessica Diniz · In-house (organization)
- Luc Thériault · Member of Parliament
- Stephanie Kusie · Member of Parliament
- Sonia Sidhu · Member of Parliament
- Blaine Calkins · Member of Parliament
and 13 moreShow fewer
- Tom Kmiec · Member of Parliament
- Élisabeth Brière · Member of Parliament
- Yasir Naqvi · Member of Parliament
- Ziad Aboultaif · Member of Parliament
- Marc Gold · Senator, Senate of Canada
- Shawn Murphy · Chief of Staff, House of Commons
- Karen Vecchio · Member of Parliament, House of Commons
- Carol Hughes · Member of Parliament, House of Commons
- Darrell Samson · Member of Parliament, House of Commons
- Marty Morantz · Member of Parliament, House of Commons
- David Wells · Senator, House of Commons
- Pam Damoff · Member of Parliament, House of Commons
- Francesco Sorbara · Member of Parliament, House of Commons
Seek increased funding for type 1 diabetes research
-
Reported by Jessica Diniz · In-house (organization)
- Mark Holland · Minister of Health, Health Canada (HC)
- Jade Mallette · Director of Parliamentary Affairs, Health Canada (HC)
Ensuring Bill C-64, the National Pharmacare Act, meets the needs of Canadians living with type 1 diabetes by having adequate insulin and diabetes devices coverage, while respecting patient choice. Read more
-
Reported by Jessica Diniz · In-house (organization)
- Sarah MacDonald · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
HealthResearch and DevelopmentScience and Technology
-
Reported by Jessica Diniz · In-house (organization)
- Jade Mallette · Director of Parliamentary Affairs, Health Canada (HC)
HealthResearch and DevelopmentScience and Technology
-
Reported by Jessica Diniz · In-house (organization)
- Mark Holland · Minister of Health, Health Canada (HC)
- Jade Mallette · Director of Parliamentary Affairs, Health Canada (HC)
HealthScience and Technology
-
Reported by Jessica Diniz · In-house (organization)
- Peter Julian · Member of Parliament, House of Commons
HealthScience and Technology
-
Reported by Jessica Diniz · In-house (organization)
- Kiara Nazon · Parliamentary Research Assistant, Senate of Canada
- Josh Dadjo · Director of Parliamentary Affairs, Senate of Canada
Health
-
Reported by Jessica Diniz · In-house (organization)
- Don Davies · Member of Parliament
BudgetHealthResearch and DevelopmentScience and Technology
-
Reported by Jessica Diniz · In-house (organization)
- Mark Holland · Minister of Health, Health Canada (HC)
BudgetHealthResearch and DevelopmentScience and Technology
-
Reported by Jessica Diniz · In-house (organization)
- Tim Louis · Member of Parliament
BudgetHealthResearch and DevelopmentScience and TechnologyTaxation and Finance
-
Reported by Jessica Diniz · In-house (organization)
- Yasir Naqvi · Member of Parliament
- Julia Duncan · Senior Policy Advisor, Health Canada (HC)
- Farangies Shah · Director of Policy, Health Canada (HC)
- Bonita Zarrillo · Member of Parliament, House of Commons
BudgetHealthResearch and DevelopmentScience and TechnologyTaxation and Finance
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.